Exercise has been shown to inhibit tumour growth in mice, and tests are now underway on cancer patients / photo: shutterstock.com
Researchers have long known that regular exercise reduces the risk of cancer and lessens the risk of its return. What wasn’t known was the mechanism behind this effect. If researchers could pinpoint the action that was triggered by exercise, this could be used to better treat cancer patients.
A team led by Dr Pernille Hojman at Copenhagen University Hospital took up the challenge, testing the effect on mice. The study had several stages. In the first stage, the team split the mice into two groups: the active group, who had running wheels in their cages, and the inactive group, who had no running wheels. All mice were injected with cancer-causing substances.
The results confirmed the premise of the study. “We found that tumour growth in the running mice was reduced by more than 50 per cent compared to the inactive mice,” says Dr Hojman. “I was surprised by the effect – it was so dramatic and convincing.”
Natural killers The next step was to test the mechanisms behind this dramatic effect. The team analysed the tumours from the mice and found that those from the active mice contained more immune cells than those from inactive mice. Specifically, there were double the number of cytotoxic T-cells, which attack cancerous cells, and five times the number of natural killer (NK) cells, which attract immune cells to a damaged area of the body.
Having discovered the presence of these cells, Dr Hojman and team embarked on the third stage of the study, in which they engineered the mice to lack either NK cells or T-cells. A lack of T-cells had little impact, but without NK cells, both active and inactive mice developed tumours of the same size. This indicated that NK cells, not T-cells, were responsible for the beneficial effect.
Finally, in an effort to explain how exercise triggers an increase in NK cells, Dr Hojman tested the hormone commonly associated with exercise – adrenalin, also known as epinephrine. When this hormone was injected into inactive mice, tumour growth was reduced by 61 per cent. However, the active mice, also given epinephrine, showed an even more impressive reduction of 74 per cent. There was clearly something else involved.
After further testing, it was found that the molecule interleukin-6, which also increases with exercise and assists immune cells, was the missing link. When the researchers injected inactive mice with both epinephrine and interleukin-6, tumour growth was slowed to the same rate as those of the active mice.
The exercise drug Dr Hojman explains why these findings are so important. “We are now testing cancer patients, and our preliminary data suggest that the mechanism is the same in humans as it was in mice.
“I think our results will help to precisely prescribe what type and amount of exercise should be performed to obtain this beneficial effect on tumour growth. We are still in the early phases, but currently we are recommending that all cancer patients perform high-intensity but short sessions of endurance training.”
It is also possible that epinephrine and interleukin-6 could be given as drugs to treat cancer patients who are too ill to be sufficiently active. ?
*Pedersen, L et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metabolism. Volume 23, Issue 3.
Active Blackpool is deploying Cornerstone Connect, a new digital interface allowing
disparate information from multiple systems to be aggregated into one dataset, to support
its focus on reducing health inequalities and improving healthy life expectancy. [more...]
Panatta brought together four of the most influential figures in bodybuilding history on the
stage of RiminiWellness 2026: Phil Heath, Lee Haney, Ronnie Coleman and Hany Rambod. [more...]
+ More featured suppliers
COMPANY PROFILES
Everyone Active
Everyone Active operates leisure centres in partnership with local councils across the UK. Today, Ev [more...]
Safe Space Lockers
We provide a full turn-key solution for clients from design and consultation, through to bespoke man [more...]
Exercise has been shown to inhibit tumour growth in mice, and tests are now underway on cancer patients / photo: shutterstock.com
Researchers have long known that regular exercise reduces the risk of cancer and lessens the risk of its return. What wasn’t known was the mechanism behind this effect. If researchers could pinpoint the action that was triggered by exercise, this could be used to better treat cancer patients.
A team led by Dr Pernille Hojman at Copenhagen University Hospital took up the challenge, testing the effect on mice. The study had several stages. In the first stage, the team split the mice into two groups: the active group, who had running wheels in their cages, and the inactive group, who had no running wheels. All mice were injected with cancer-causing substances.
The results confirmed the premise of the study. “We found that tumour growth in the running mice was reduced by more than 50 per cent compared to the inactive mice,” says Dr Hojman. “I was surprised by the effect – it was so dramatic and convincing.”
Natural killers The next step was to test the mechanisms behind this dramatic effect. The team analysed the tumours from the mice and found that those from the active mice contained more immune cells than those from inactive mice. Specifically, there were double the number of cytotoxic T-cells, which attack cancerous cells, and five times the number of natural killer (NK) cells, which attract immune cells to a damaged area of the body.
Having discovered the presence of these cells, Dr Hojman and team embarked on the third stage of the study, in which they engineered the mice to lack either NK cells or T-cells. A lack of T-cells had little impact, but without NK cells, both active and inactive mice developed tumours of the same size. This indicated that NK cells, not T-cells, were responsible for the beneficial effect.
Finally, in an effort to explain how exercise triggers an increase in NK cells, Dr Hojman tested the hormone commonly associated with exercise – adrenalin, also known as epinephrine. When this hormone was injected into inactive mice, tumour growth was reduced by 61 per cent. However, the active mice, also given epinephrine, showed an even more impressive reduction of 74 per cent. There was clearly something else involved.
After further testing, it was found that the molecule interleukin-6, which also increases with exercise and assists immune cells, was the missing link. When the researchers injected inactive mice with both epinephrine and interleukin-6, tumour growth was slowed to the same rate as those of the active mice.
The exercise drug Dr Hojman explains why these findings are so important. “We are now testing cancer patients, and our preliminary data suggest that the mechanism is the same in humans as it was in mice.
“I think our results will help to precisely prescribe what type and amount of exercise should be performed to obtain this beneficial effect on tumour growth. We are still in the early phases, but currently we are recommending that all cancer patients perform high-intensity but short sessions of endurance training.”
It is also possible that epinephrine and interleukin-6 could be given as drugs to treat cancer patients who are too ill to be sufficiently active. ?
*Pedersen, L et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metabolism. Volume 23, Issue 3.
According to research which tracked more than 147,000 people for 30 years, 90-120 minutes
of strength training a week may deliver some of the biggest long-term health rewards.
The UK's four Chief Medical Officers have published a refreshed edition of Physical activity
guidelines: UK Chief Medical Officers' report, updating the evidence that underpins the nation's
physical activity recommendations and placing greater emphasis on strength, balance, reducing
sedentary behaviour and, for the first time, supporting people taking weight loss medications.
Places Leisure has exchanged contracts to build and operate a flagship £60m water and leisure
destination on behalf of Basingstoke and Deane Borough Council.
The Republic of Ireland will become the latest market in PureGym’s expanding international
portfolio, with the first launch planned for Dublin in 2027.
Anytime Fitness opened more than one club a day in 2025 and is on track to maintain this rate
of growth this year, as parent company Purpose Brands targets further international expansion.
The £33.9 million Leighton Leisure and Community Centre has opened in Leighton Buzzard, UK,
creating a next-generation public leisure, health and wellbeing hub for the local community.
Walnuts Leisure Centre in Orpington, in the London Borough of Bromley, has reopened following
a £17m transformation designed to secure the long-term future of the public leisure asset and
reposition it as a community wellbeing hub.
The Gym Group, has announced that it's sustained positive trading momentum has continued
through the first half of 2026 and the company remains confident about the outlook.
Active Blackpool is deploying Cornerstone Connect, a new digital interface allowing
disparate information from multiple systems to be aggregated into one dataset, to support
its focus on reducing health inequalities and improving healthy life expectancy. [more...]
Panatta brought together four of the most influential figures in bodybuilding history on the
stage of RiminiWellness 2026: Phil Heath, Lee Haney, Ronnie Coleman and Hany Rambod. [more...]
+ More featured suppliers
COMPANY PROFILES
Everyone Active Everyone Active operates leisure centres in partnership with local councils across the UK. Today, Ev [more...]
